Publications by authors named "Christopher Berger"

Claim this Profile
P
Predicted choice and acceptability of regimens for tuberculosis preventive treatment among people living with HIV in Uganda - a discrete choice experiment.
Hélène E Aschmann, Allan Musinguzi, Jillian L Kadota, Catherine Namale, Juliet Kakeeto, Christopher Berger

medRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment.
Hélène E Aschmann, Allan Musinguzi, Jillian L Kadota, Catherine Namale, Juliet Kakeeto, Christopher Berger

J Int AIDS Soc· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda.
Jillian L Kadota, Allan Musinguzi, Hélène E Aschmann, Lydia Akello, Fred Welishe, Christopher A Berger

Open Forum Infect Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.
Allan Musinguzi, Joan R Kasidi, Jillian L Kadota, Fred Welishe, Anne Nakitende, Christopher A Berger

PLOS Glob Public Health· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events reported during weekly isoniazid-rifapentine (3HP) tuberculosis preventive treatment among people living with HIV in Uganda.
Jillian L Kadota, Allan Musinguzi, Hélène E Aschmann, Lydia Akello, Fred Welishe, Christopher A Berger

medRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optogenetic control of kinesin-1, -2, -3 and dynein reveals their specific roles in vesicular transport.
Sahil Nagpal, Karthikeyan Swaminathan, Daniel Beaudet, Maud Verdier, Samuel Wang, Christopher L Berger, Florian Berger

Cell Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial.
Allan Musinguzi, Joan R Kasidi, Jillian L Kadota, Fred Welishe, Anne Nakitende, Christopher A Berger

medRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The types and numbers of kinesins and dyneins transporting endocytic cargoes modulate their motility and response to tau.
Daniel Beaudet, Christopher L Berger, Adam G Hendricks

J Biol Chem· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 3 optimized delivery strategies for completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV in Uganda: A single-center randomized trial.
Fred C Semitala, Jillian L Kadota, Allan Musinguzi, Fred Welishe, Anne Nakitende, Christopher A Berger

PLoS Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of the neck-linker of KIF18A alters Microtubule subpopulation preference.
Katelyn A Queen, Alisa Cario, Christopher L Berger, Jason Stumpff

Mol Biol Cell· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences of people living with HIV for features of tuberculosis preventive treatment regimens - a discrete choice experiment.
Hélène E Aschmann, Allan Musinguzi, Jillian L Kadota, Catherine Namale, Juliet Kakeeto, Christopher Berger

medRxiv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tau, microtubule dynamics, and axonal transport: New paradigms for neurodegenerative disease.
Alisa Cario, Christopher L Berger

Bioessays· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda.
Noah Kiwanuka, Alex Kityamuwesi, Rebecca Crowder, Kevin Guzman, Christopher A Berger

PLOS Digit Health· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modification of the Neck Linker of KIF18A Alters Microtubule Subpopulation Preference.
Katelyn A Queen, Alisa Cario, Christopher L Berger, Jason Stumpff

bioRxiv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers and Facilitators to Implementing a Digital Adherence Technology for Tuberculosis Treatment Supervision in Uganda: Qualitative Study.
Anna Leddy, Joseph Ggita, Christopher A Berger, Alex Kityamuwesi, Agnes Nakate Sanyu

J Med Internet Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous motor imagery and visual feedback of finger movement elicit the moving rubber hand illusion, at least in illusion-susceptible individuals.
Christopher C Berger, Sara Coppi, H Henrik Ehrsson

Exp Brain Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tau differentially regulates the transport of early endosomes and lysosomes.
Linda Balabanian, Dominique V Lessard, Karthikeyan Swaminathan, Pamela Yaninska, Muriel Sébastien, Christopher L Berger

Mol Biol Cell· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The N-terminal disease-associated R5L Tau mutation increases microtubule shrinkage rate due to disruption of microtubule-bound Tau patches.
Alisa Cario, Sanjula P Wickramasinghe, Elizabeth Rhoades, Christopher L Berger

J Biol Chem· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence trajectory as an on-treatment risk indicator among drug-resistant TB patients in the Philippines.
Sophie Huddart, Donna Mae Geocaniga-Gaviola, Rebecca Crowder, Alexander Rupert Lim, Evanisa Lopez, Christopher A Berger

PLoS One· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pathogenic R5L mutation disrupts formation of Tau complexes on the microtubule by altering local N-terminal structure.
Alisa Cario, Adriana Savastano, Neil B Wood, Zhu Liu, Michael J Previs, Christopher L Berger

Proc Natl Acad Sci U S A· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.
Fred C Semitala, Jillian L Kadota, Allan Musinguzi, Juliet Nabunje, Fred Welishe, Christopher A Berger

PLoS Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda-patient and health worker perspectives.
Fred C Semitala, Allan Musinguzi, Jackie Ssemata, Fred Welishe, Juliet Nabunje, Christopher A Berger

Implement Sci Commun· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda.
Adithya Cattamanchi, Rebecca Crowder, Alex Kityamuwesi, Noah Kiwanuka, Maureen Lamunu, Christopher Berger

PLoS Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iterative Adaptation of a Tuberculosis Digital Medication Adherence Technology to Meet User Needs: Qualitative Study of Patients and Health Care Providers Using Human-Centered Design Methods.
Devika Patel, Christopher Allen Berger, Alex Kityamuwesi, Joseph Ggita, Lynn Kunihira Tinka

JMIR Form Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol and implementation details for a pragmatic, stepped-wedge cluster randomised trial of a digital adherence technology to facilitate tuberculosis treatment completion.
Rebecca Crowder, Alex Kityamuwesi, Noah Kiwanuka, Maureen Lamunu, Catherine Namale, Christopher Allen Berger

BMJ Open· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis